AlphaMaven AlphaMaven

Investors opposing DCC bid selling shares at prices below US private equity offer

Reported by Irishtimes
Aug 15, 2026· 3 min read
Save Post LinkedIn Email
Key Takeaways
  • • DCC's top three institutional shareholders—Ninety One, Aviva Investors, and Fidelity International—are actively opposing a £5.7 billion ($7.63 billion) private equity takeover bid, publicly declaring the offer undervalues the FTSE 100 company's long-term growth potential.
  • • The KKR and Energy Capital Partners consortium raised its offer to £65.25 per share plus £1.47 in dividends (approximately 7.8% premium to DCC's prior closing price), up from an initial £58-per-share proposal, but institutional investors remain unconvinced the valuation reflects fair value.
  • • Major shareholders argue the bid fails to account for DCC's strategic position as a pure-play energy distribution business following its 2024-2025 divestiture program, which generated approximately £1.1 billion in proceeds from the sale of its health and infotech divisions and repositioned the company for exposure to Europe's energy transition and security imperatives.
  • • Investor resistance signals a shift in M&A dynamics, where traditional takeover premiums alone are insufficient to overcome shareholder conviction that a company's independent strategic trajectory offers superior long-term value creation.
Summary
DCC plc faces a significant shareholder revolt against a £5.7 billion takeover proposal from a US private equity consortium comprising KKR and Energy Capital Partners (a Bridgepoint subsidiary). The consortium initially submitted a £58-per-share offer, which was subsequently increased to £65.25 per share plus £1.47 in dividends, valuing the transaction at approximately £5.7 billion. Despite the revised offer representing a material premium, DCC's three largest institutional shareholders—Ninety One, Aviva Investors, and Fidelity International—have publicly opposed the bid, arguing it fundamentally undervalues the Ireland-based energy distribution company.

Aviva Investors' head of UK equities, Matt Bennison, stated the proposal "significantly undervalues" DCC and expressed disappointment at the prospect of the board recommending an offer at £65.25 per share. Similarly, Fidelity International's UK equity fund manager, Alex Wright, contended that the revised proposal inadequately reflects DCC's fair value and long-term growth potential. This coordinated opposition from three of DCC's most influential shareholders represents a substantial impediment to the consortium's acquisition strategy, particularly given the institutional shareholding concentration within UK-listed energy and industrial companies.

The shareholder resistance is rooted in DCC's strategic repositioning over 2024-2025. In 2024, the company announced a three-way business split to focus on its energy division. Subsequently, it divested its health division to Investindustrial for approximately £1 billion and sold its UK and Ireland infotech business to Aurelius for £100 million, totaling roughly £1.1 billion in proceeds. Management identified energy as the company's "largest growth opportunity," citing secular tailwinds from European energy transition initiatives and heightened energy security imperatives across the continent. Institutional investors appear to view these strategic actions as evidence that DCC's independent trajectory—as a focused energy distribution platform—offers superior value realization than a leveraged private equity ownership structure.

This transaction exemplifies a broader shift in takeover dynamics, where traditional M&A premiums have become insufficient to overcome shareholder conviction regarding a company's standalone strategic value. The resistance suggests that sophisticated institutional investors are increasingly willing to challenge acquisition proposals, particularly when a company has demonstrable exposure to structural growth drivers such as energy transition and geopolitical supply chain repositioning.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Irishtimes Investors opposing DCC bid selling shares at prices below US private equity offer